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Abstract
Purpose Heroin has a half-life of 2–6 min and is
metabolized too quickly to be detected in autopsy samples.
The presence of 6-acetylmophine (6-AM) in urine, blood,
or other samples is convincing evidence of heroin use by a
decedent, but 6-AM itself has a half-life of 6–25 min
before it is hydrolyzed to morphine, so 6-AM may not be
present in sufficient concentration to detect in postmortem
samples. Codeine is often present in heroin preparations as
an impurity and is not a metabolite of heroin. Studies report
that a ratio of morphine to codeine greater than one indi-
cates heroin use. We hypothesize that the ratio of morphine
to codeine in our decedents abusing drugs intravenously
will be no different in individuals with 6-AM present than
in individuals where no 6-AM is detected, and we report
our study of this hypothesis.
Methods All accidental deaths investigated by the Jef-
ferson County Coroner/Medical Examiner Office from
2010 to 2013 with morphine detected in blood samples
collected at autopsy were reviewed. Five deaths where
trauma caused or contributed to death were excluded from
the review. The presence or absence of 6-AM and the
concentrations of morphine and codeine were recorded for
each case. The ratio of morphine to codeine was calculated
for all decedents. Any individual in whom no morphine or
codeine was detected in a postmortem sample was exclu-
ded from further study. Absence or presence of drug
paraphernalia or evidence of intravascular (IV) drug use
was documented in each case to identify IV drug users. The
proportion of the IV drug users with and without 6-AM
present in a postmortem sample was compared to the M/C
ratio for the individuals.
Results Of the 230 deaths included in the analysis, 103 IV
drug users with quantifiable morphine and codeine in a
postmortem sample were identified allowing for calcula-
tion of an M/C ratio. In these IV drug users, the M/C ratio
was greater than 1 in 98 % of decedents. When controlling
for the absence or presence of 6-AM there was no statis-
tically significant difference in the proportion of IV drug
users when compared to non IV drug users with an M/C
ratio of greater than 1 (p = 1.000).
Conclusion The M/C ratio in IV drug users, if greater
than 1, is seen in deaths due to heroin toxicity where 6-AM
is detected in a postmortem sample. This study provides
evidence that a M/C ratio greater than one in an IV drug
user is evidence of a death due to heroin toxicity even if
6-AM is not detected in the blood. Using the M/C ratio, in
addition to scene and autopsy findings, provides sufficient
evidence to show heroin is the source of the morphine and
codeine. Listing heroin as a cause or contributing factor in
deaths with evidence of IV drug abuse and where the M/C
ratio exceeds 1 will improve identification of heroin
fatalities, which will allow better allocation of resources
for public health initiatives.
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Introduction
Because heroin is rapidly deacetylated in whole blood, the
presence of 6-acetylmorphine (6-AM) in postmortem
samples of urine or blood is often used to identify heroin
use by a decedent [1, 2]. However, 6-AM has a half-life of
6–25 min before it is metabolized to morphine in the liver
[2]. Furthermore, codeine is often present in heroin as an
impurity, and not produced by metabolism of the drug.
Typically, only small amounts of codeine are detected in
samples and researchers have used a morphine to codeine
ratio greater than one and the presence of 6-AM in a
postmortem sample to identify cases of heroin use [3–5].
Because of the rapid metabolization of heroin and 6-AM,
morphine and codeine may be the only substances detected
in postmortem samples in cases of heroin use [3–5]. To
confirm that cases are being properly classified as deaths
due to heroin toxicity, we examined the ratio of morphine
to codeine in decedents with and without evidence of
intravenous drug use and correlated the ratios with the
absence or presence of 6-AM in a postmortem samples. We
hypothesize that there will be no difference in the pro-
portion of cases in which the blood morphine to codeine
ratio exceeds one in IV drug users with 6-AM detected in a
postmortem sample when compared to IV drug users
without 6-AM detected in a postmortem sample. If this
hypothesis is correct then it has important implications for
death certification in that it would be appropriate to classify
a death as heroin toxicity with a blood morphine to codeine
ratio exceeding one in a setting that suggests IV drug use
even in the absence of 6-acetylmorphine. We report here
the results of this analysis.
Methods
All unnatural or suspicious deaths occurring in Jefferson
County, Alabama are investigated by the Jefferson County
Coroner/Medical Examiner Office (JCCME). Samples of
blood, urine, vitreous humor, liver tissue, and brain tissue
are routinely collected (if possible) in all cases and sub-
mitted for toxicological analyses for drugs of abuse. The
analyses are performed by the Forensic Toxicology Labo-
ratory at the University of Alabama at Birmingham by
contract with the JCCME. Toxicology reports indicate the
absence or presence of 6-AM in screening tests of urine
and blood. Notably, 6-acetylmorphine is routinely tested
for in urine samples (when urine is available) using
Enzyme Multiplied Immunoassay Technique (EMIT). If no
urine is available for testing, a blood sample is tested using
EMIT. Additional testing of other samples for 6-acetyl-
morphine is not routinely performed and only samples of
urine or blood were screened during the time period of
selected cases. If 6-AM or opiates are detected by EMIT
then additional testing is performed to confirm the presence
of morphine, codeine, and 6-AM (if present) in samples of
blood with quantitation. In most cases a positive 6-AM was
from a sample of urine; however, for purposes of the
analysis, a positive blood or urine 6-AM are considered
unequivocal. Information from the toxicology report and
evidence of intravascular (IV) drug use is collected in the
JCCME case management database for each case. A search
of the database for accidental deaths in 2010–2013 in
which morphine was detected in a postmortem sample was
performed. From these cases only deaths due to drug tox-
icity (drug overdose deaths) were included in the study.
Cases where trauma was listed as the cause of death and
drug use was listed as a contributory cause of death (motor
vehicle fatalities) were also excluded. In every case, toxi-
cology reports were reviewed and the concentrations of
morphine and codeine were documented. If codeine was
not detected in a case, a result of ‘‘not detected’’ was
recorded. The absence or presence of 6-AM was also
recorded for each case. In every case, the files were
reviewed to determine if the decedent was an IV drug user.
Criteria for inclusion as an IV drug user included the
presence of needles or syringes at the scene, a reported
history of IV drug use to investigators, identification of a
recent needle puncture mark on the body not related to
medical attention, needle track marks identified on the
body, or polarizable foreign body material in pulmonary
lymphovascular spaces identified during microscopic
examination.
From the collected data, a morphine to codeine ratio (M/
C ratio) was calculated in every case that had a quantifiable
amount of morphine and codeine in a postmortem sample
[4]. From decedents with a quantifiable M/C ratio, the
proportion of cases in which the M/C ratio was greater than
one was compared between IV drug users and non-IV drug
users. In addition, the proportion of cases in which the M/C
ratio was greater than one was compared between IV drug
users with 6-AM present or absent in a sample. Using this
information, an algorithm for interpreting toxicological
results in cases with morphine and codeine detected in a
postmortem sample was designed.
Results
We identified 190 deaths due to drug toxicity. From this
sample, 110 decedents had 6-AM detected in a postmortem
sample. Of these cases, 108 (98 %) had a morphine to
codeine ratio of greater than one as would be expected in
decedents using heroin. From the original 190 cases, 127
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IV drug users were identified, of whom 103 had quantifi-
able morphine and codeine detected in a postmortem
sample. The postmortem sample was always a blood
sample and most commonly was blood collected from the
internal iliac veins at autopsy. All but two (98 %) of the
103 decedents had an M/C ratio of greater than one.
Among the 63 non-IV drug users with quantifiable mor-
phine and codeine detected, all but one (98 %) had an M/C
ratio of greater than one (Table 1). Compared to all IV
drug users this difference was not statistically significant
(p = 1.00). Of the 103 IV drug users with quantifiable
morphine and codeine in a postmortem sample, 69 dece-
dents (68 %) had 6-AM detected in a postmortem sample
and 34 (33 %) had no 6-AM detected in a postmortem
sample. When compared to the 63 non-IV drug users with
quantifiable morphine and codeine detected, 41 decedents
had 6-AM detected in a postmortem sample (p = 0.87).
A total of 166 cases with quantifiable morphine and
codeine in a postmortem sample were also analyzed. From
these cases 163 deaths had an M/C ratio of greater than
one. From the 163 cases, 108 had 6-AM detected in a
postmortem sample. Of the remaining 55 decedents, 6-AM
was not detected in a postmortem sample; however, 33 of
the decedents were IV drug users (Table 2). Our study has
found no statistically significant difference between indi-
viduals with a history of intravenous drug abuse and
individuals with no known history of intravenous drug
abuse with respect to either M/C ratio[1 or the presence of
6-AM. Therefore, we conclude that M/C[ 1 in an IV drug
user is sufficient evidence to infer heroin use by a decedent
even if 6-AM is not detected in a postmortem sample. The
only exception to making a diagnosis of heroin use by such
inference would be the presence of various medications
that contain morphine sulfate and codeine at the scene of
death.
These data allowed for classification of deaths as ‘‘her-
oin toxicity’’ when an M/C ratio exceeded one, evidence of
IV drug use was identified by investigation or postmortem
examination, and no 6-AM was detected in a postmortem
sample.
Discussion
Based on data from the CDC approximately 43,000 acci-
dental deaths due to drug toxicity were reported on death
certificates in 2013 [6]. Other studies have reported con-
cern for underreporting of deaths due to heroin use because
the inability to identify 6-AM in a postmortem sample,
leads to classification of these deaths as being due to
morphine use [3, 7, 8]. These studies suggest that heroin
toxicity may be responsible for overestimating the contri-
bution of prescription opiates to accidental deaths in the
United States [3, 7, 8]. Other studies have suggested that
codeine is also over reported as a cause of unintentional
drug overdose deaths for similar reasons [9, 10].
When interpreting toxicological results from a post-
mortem sample, forensic pathologists must not only con-
sider what drugs are detected, but also drug concentrations,
and ratios [5, 11, 12]. The ratio of morphine to codeine is
of paramount importance as morphine is a metabolite of
heroin and codeine, and detection of morphine could
indicate the use of either drug or use of morphine sulfate
[4, 5, 12–14]. A morphine to codeine ratio of less than one
suggests use of codeine, and a morphine to codeine ratio of
greater than one suggest heroin use or use of morphine
sulfate [4, 5, 12, 13]. Codeine is an alkaloid prepared from
opium poppy (Papaver somniferum) by methylation. Her-
oin produced from opium often contains small amounts of
codeine as an impurity [15, 16]. Some research suggests
that some commercial morphine sulfate preparations may
Table 1 Comparison of IV and non-IV drug users
Total M and C present in samplea 6-AM presentb M/C[ 1 Morphine range Codeine range
IV drug user 127 103 69 101 Min: 0.130 mg/L
Max: 1.48 mg/L
Min: 0.002 mg/L
Max: 0.180 mg/L
Non-IV drug user 63 63 41 62 Min: 0.016 mg/L
Max: 1.70 mg/L
Min: 0.002 mg/L
Max: 0.042 mg/L
a Both morphine and codeine must be present in quantifiable concentrations
b 6-AM present in urine or blood by EMIT
Table 2 Comparison of all cases with quantifiable Morphine and
Codeine
Total 6-AM presenta IV drug use positiveb
M/C[ 1 163 108 33
M/C\ 1 3 2 0
a 6-AM present in urine or blood by EMIT
b IV drug users with no 6-AM detected in a postmortem sample
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also contain codeine, while other researchers have sug-
gested that codeine is a minor metabolite of morphine
sulfate in humans [14–16]. When a morphine to codeine
ratio of greater than one is encountered, additional toxi-
cological testing for 6-AM may be all that is needed to
discern a case of heroin use [1]. Furthermore, 6-AM pos-
itivity in urine or blood can outweigh an M/C ratio of less
than one as it did in two cases. These cases were properly
classified as deaths due to heroin use. However, if 6-AM
cannot be detected, and the M/C ratio is greater than one,
then the absence or presence of evidence of IV drug use
should be considered. If an individual has a morphine to
codeine ratio of greater than one and evidence of IV drug
use is identified by investigation (needles/syringes/spoon at
scene) or at autopsy (needle track marks/recent needle
puncture mark not placed during medical intervention/po-
larizable material in pulmonary lymphovascular spaces);
an overdose death can be classified as heroin toxicity
without identifying 6-AM in a postmortem sample. The
Jefferson County Coroner/Medical Examiner Office uses
an algorithm for classification of deaths where both mor-
phine and codeine are detected in a postmortem sample
(Fig. 1).
Because national surveillance of opiate related fatalities
is based on death certificate data, proper classification of
deaths is imperative. Testing of additional samples for
6-AM may help to discern deaths due to heroin; however,
information from scene investigations or the postmortem
examination identifying a decedent as an IV drug user can
identify a death due to heroin toxicity when 6-AM is not
detected in a postmortem sample. We suggest the classi-
fication of heroin toxicity, morphine toxicity, or codeine
toxicity using the algorithm listed above after consideration
of the findings at autopsy, interpretation of postmortem
toxicological testing, and correlation of scene investiga-
tions. If cases do not fit the algorithm or conflicting evi-
dence at the scene does not correlate with the toxicological
results, a classification of ‘‘opiate toxicity’’ may be applied;
however, after using the classification algorithm for
3 years, one of the authors (GGD) has not received any
complaints from family members, law enforcement, or the
Alabama Department of Heath questioning the validity of
ascribing death to the effects of heroin on the Death Cer-
tificate in those cases. Furthermore, scene investigations
haven’t discovered medications containing morphine and
codeine at scenes in cases with an M/C ratio of greater than
1 and no 6-AM detected in a postmortem sample. As we
alluded in the algorithm, such a possibility exists; however,
in our experience such a scenario has not occurred.
We do not claim that the algorithm we recommend is
infallible, but infallibility is not a requirement for death
certification. The cause of death is a diagnosis, which is an
opinion. As forensic pathologists we regularly ascribe
death to the effects of coronary artery atherosclerosis, even
when we have no evidence for myocardial infarction
beyond sudden, unexpected death and at least one coronary
artery significantly narrowed by plaque and no other ana-
tomic or toxicological cause for death. Clinicians some-
times find this practice irresponsible, claiming that without
ECG changes or elevated biochemical markers we cannot
Both morphine and codeine 
quantated in blood sample. (N=166)
Calculate M/C rao. M/C rao is less than 1: Codeine use. 
(N=1)*
M/C rao is greater than 1.
(N=163)
Is 6-AM present in a sample?
Yes: Heroin use. 
(N=108)  
No: Connue. 
(N=55)
No:  Morphine use.  
(N=22) **
Is there evidence of IV drug use 
at scene or at autopsy? 
Yes: Heroin use.
(N=33)**
Fig. 1 Interpreting morphine and codeine detected by toxicological
testing: single asterisk Two other cases in our study had an M/C ratio
of less than one; however, 6-AM was present in a sample. These cases
were classified as ‘‘heroin use’’ as 6-AM will override an M/C ratio of
less than 1. Double asterisk an exception to making a diagnosis of
heroin use by such inference would be allowed if the presence of
various medications that contain morphine sulfate and codeine were
found at the scene of death
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make a determination that coronary artery disease caused
death. The algorithm that we recommend for classification
of these selected cases is analogous. By using this algo-
rithm a forensic pathologist who ascribes death to heroin
toxicity will be correct in the vast majority of cases, and in
doing so forensic pathologists will provide the public
health system a far more accurate determination of the
contribution of heroin to death. Proper classification of
these deaths will allow for better guidance of public health
strategies and action plans to enhance medical rehabilita-
tion programs and prevent these deaths.
Key points
1. Deaths due to heroin toxicity can be identified even if
no 6-acetylmorphine can be detected in samples of
urine or blood collected at autopsy.
2. When both morphine and codeine are detected and
quantified in a postmortem sample of blood in a death
due to an apparent intoxication a morphine to codeine
ratio (M/C ratio) can be calculated. In these cases,
presence or absence of evidence of intravascular drug
use should also be considered.
3. Our study has found no statistically significant differ-
ence between individuals with a history of intravenous
drug abuse and individuals with no known history of
intravenous drug abuse with respect to either M/C ratio
[1 or the presence of 6-AM.
4. If the M/C ratio is greater than one, and there is
evidence that the decedent is an intravascular drug
user, then a death due to heroin use can be identified in
cases where 6-AM was not detected in a postmortem
sample.
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